Ott, Katja

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 16.

Journal Article

Reim, Daniel; Novotny, Alexander; Friess, Helmut; Slotta-Huspenina, Julia; Weichert, Wilko; Ott, Katja; Dislich, Bastian; Lorenzen, Sylvie; Becker, Karen; Langer, Rupert (2020). Significance of tumour regression in lymph node metastases of gastric and gastro-oesophageal junction adenocarcinomas. The journal of pathology: clinical research, 6(4), pp. 263-272. Wiley 10.1002/cjp2.169

Galván, José A.; Wiprächtiger, Julia; Slotta-Huspenina, Julia; Feith, Marcus; Ott, Katja; Kröll, Dino; Seiler, Christian A.; Langer, Rupert (2020). Immunohistochemical analysis of the expression of cancer-associated fibroblast markers in esophageal cancer with and without neoadjuvant therapy. Virchows Archiv, 476(5), pp. 725-734. Springer 10.1007/s00428-019-02714-6

Adams, Olivia; Janser, Félice A.; Dislich, Bastian; Berezowska, Sabina; Humbert, Magali; Seiler, Christian A.; Kröll, Dino; Slotta-Huspenina, Julia; Feith, Marcus; Ott, Katja; Tschan, Mario P.; Langer, Rupert (2019). Correction: A specific expression profile of LC3B and p62 is associated with nonresponse to neoadjuvant chemotherapy in esophageal adenocarcinomas. PLoS ONE, 14(10), e0224832. Public Library of Science 10.1371/journal.pone.0224832

Adams, Olivia; Janser, Félice A.; Dislich, Bastian; Berezowska, Sabina; Humbert, Magali; Seiler, Christian A.; Kroell, Dino; Slotta-Huspenina, Julia; Feith, Marcus; Ott, Katja; Tschan, Mario P.; Langer, Rupert (2018). A specific expression profile of LC3B and p62 is associated with nonresponse to neoadjuvant chemotherapy in esophageal adenocarcinomas. PLoS ONE, 13(6), e0197610. Public Library of Science 10.1371/journal.pone.0197610

Jesinghaus, Moritz; Steiger, Katja; Slotta-Huspenina, Julia; Drecoll, Enken; Pfarr, Nicole; Meyer, Petra; Konukiewitz, Björn; Bettstetter, Marcus; Wieczorek, Kathrin; Ott, Katja; Feith, Markus; Langer, Rupert; Weichert, Wilko; Specht, Katja; Boxberg, Melanie (2017). Increased intraepithelial CD3+ T-lymphocytes and high PD-L1 expression on tumor cells are associated with a favorable prognosis in esophageal squamous cell carcinoma and allow prognostic immunogenic subgrouping. OncoTarget, 8(29), pp. 46756-46768. Impact Journals LLC 10.18632/oncotarget.18606

Springfeld, Christoph; Wiecha, Christiane; Kunzmann, Romy; Heger, Ulrike; Weichert, Wilko; Langer, Rupert; Stange, Annika; Blank, Susanne; Sisic, Leila; Schmidt, Thomas; Lordick, Florian; Jäger, Dirk; Grenacher, Lars; Bruckner, Tom; Büchler, Markus W; Ott, Katja (2015). Influence of Different Neoadjuvant Chemotherapy Regimens on Response, Prognosis, and Complication Rate in Patients with Esophagogastric Adenocarcinoma. Annals of surgical oncology, 22(Suppl 3), pp. 905-914. Springer 10.1245/s10434-015-4617-x

Blank, Susanne; Lordick, Florian; Bader, Franz; Burian, Maria; Dobritz, Martin; Grenacher, Lars; Becker, Karen; Weichert, Wilko; Langer, Rupert; Sisic, Leila; Stange, Annika; Jäger, Dirk; Büchler, Markus; Bruckner, Thomas; Siewert, Jörg; Ott, Katja (2015). Post-therapeutic response evaluation by a combination of endoscopy and CT scan in esophagogastric adenocarcinoma after chemotherapy: better than its reputation. Gastric cancer, 18(2), pp. 314-325. Springer 10.1007/s10120-014-0367-x

Bauer, Lukas; Takacs, Agnes; Slotta-Huspenina, Julia; Langer, Rupert; Becker, Karen; Novotny, Alexander; Ott, Katja; Walch, Axel; Hapfelmeier, Alexander; Keller, Gisela (2015). Clinical Significance of NOTCH1 and NOTCH2 Expression in Gastric Carcinomas: An Immunohistochemical Study. Frontiers in oncology, 5(94), p. 94. Frontiers Research Foundation 10.3389/fonc.2015.00094

Karamitopoulou, Evanthia; Thies, Svenja; Zlobec, Inti; Ott, Katja; Feith, Marcus; Slotta-Huspenina, Julia; Lordick, Florian; Becker, Karen; Langer, Rupert (2014). Assessment of tumor regression of esophageal adenocarcinomas after neoadjuvant chemotherapy: comparison of 2 commonly used scoring approaches. The American journal of surgical pathology, 38(11), pp. 1551-1556. Lippincott Williams & Wilkins 10.1097/PAS.0000000000000255

Aichler, Michaela; Motschmann, Martin; Jütting, Uta; Luber, Birgit; Becker, Karen; Ott, Katja; Lordick, Florian; Langer, Rupert; Feith, Marcus; Siewert, Jörg Rüdiger; Walch, Axel (2014). Epidermal growth factor receptor (EGFR) is an independent adverse prognostic factor in esophageal adenocarcinoma patients treated with cisplatin-based neoadjuvant chemotherapy. OncoTarget, 5(16), pp. 6620-6632. Impact Journals LLC

Heger, Ulrike; Blank, Susanne; Wiecha, Christiane; Langer, Rupert; Weichert, Wilko; Lordick, Florian; Bruckner, Thomas; Dobritz, Martin; Burian, Maria; Springfeld, Christoph; Grenacher, Lars; Siewert, Jörg-Rüdiger; Büchler, Markus; Ott, Katja (2014). Is preoperative chemotherapy followed by surgery the appropriate treatment for signet ring cell containing adenocarcinomas of the esophagogastric junction and stomach? Annals of surgical oncology, 21(5), pp. 1739-1748. Springer 10.1245/s10434-013-3462-z

Langer, Rupert; Becker, Karen; Zlobec, Inti; Gertler, Ralf; Sisic, Leila; Büchler, Markus; Lordick, Florian; Slotta-Huspenina, Julia; Weichert, Wilko; Höfler, Heinz; Feith, Marcus; Ott, Katja (2014). A multifactorial histopathologic score for the prediction of prognosis of resected esophageal adenocarcinomas after neoadjuvant chemotherapy. Annals of surgical oncology, 21(3), pp. 915-921. Springer 10.1245/s10434-013-3410-y

Heger, Ulrike; Bader, Franz; Lordick, Florian; Burian, Maria; Langer, Rupert; Dobritz, Martin; Blank, Susanne; Bruckner, Thomas; Becker, Karen; Herrmann, Ken; Siewert, Jörg-Rüdiger; Ott, Katja (2014). Interim endoscopy results during neoadjuvant therapy for gastric cancer correlate with histopathological response and prognosis. Gastric cancer, 17(3), pp. 478-488. Springer 10.1007/s10120-013-0296-0

Blank, Susanne; Rachakonda, Sivaramakrishna; Keller, Gisela; Weichert, Wilko; Lordick, Florian; Langer, Rupert; Springfeld, Christoph; Bruckner, Thomas; Becker, Karen; Kumar, Rajiv; Ott, Katja (2014). A retrospective comparative exploratory study on two methylentetrahydrofolate reductase (MTHFR) polymorphisms in esophagogastric cancer: the A1298C MTHFR polymorphism is an independent prognostic factor only in neoadjuvantly treated gastric cancer patients. BMC cancer, 14(58), p. 58. BioMed Central 10.1186/1471-2407-14-58

Ott, Katja; Blank, Susanne; Becker, Karen; Langer, Rupert; Weichert, Wilko; Roth, Wilfried; Sisic, Leila; Stange, Annika; Jäger, Dirk; Büchler, Markus; Siewert, Jörg-Rüdiger; Lordick, Florian (2012). Factors predicting prognosis and recurrence in patients with esophago-gastric adenocarcinoma and histopathological response with less than 10 % residual tumor. Langenbeck's archives of surgery, 398(2), pp. 239-249. Berlin: Springer 10.1007/s00423-012-1039-0

Bauer, Lukas; Langer, Rupert; Becker, Karen; Hapfelmeier, Alexander; Ott, Katja; Novotny, Alexander; Höfler, Heinz; Keller, Gisela (2012). Expression profiling of stem cell-related genes in neoadjuvant-treated gastric cancer: a NOTCH2, GSK3B and β-catenin gene signature predicts survival. PLoS ONE, 7(9), e44566. Lawrence, Kans.: Public Library of Science 10.1371/journal.pone.0044566

This list was generated on Tue Apr 16 10:30:31 2024 CEST.
Provide Feedback